Clinical Trial

Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated March 11, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
there will be 2 groups of patients with acute coronary syndrome. The patients will receive one of the 2 study drugs and impact on raising Vitamin D level will be seen after 6 months
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-03.
Status change: Not Yet Recruiting → Recruiting 2025-03-07
Trial Details
NCT Number NCT06765265
Lead Sponsor King Edward Medical University
Conditions Acute Coronary Syndromes
Enrollment 152 participants
Start Date 2025-01-05
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-11